The biostimulants market in Asia Pacific is expected to grow from US$ 734.41 million in 2022 to US$ 1,419.36 million by 2028; it is estimated to grow at a CAGR of 11.6% from 2022 to 2028.
In the last few decades, technological innovations have been proposed to enhance the sustainability of agricultural production systems by significantly reducing synthetic agrochemicals such as pesticides and fertilizers. A promising eco-friendly innovation would be using natural plant biostimulants (PBs) that enhance flowering, plant growth, fruit set, crop productivity, and nutrient use efficiency (NUE) and can also improve the tolerance against a wide range of abiotic stressors. Due to technological advancements in the biostimulants and plant-growth promotor categories, manufacturers have a chance to develop new products in the biostimulants industry. The use of biostimulants as a stimulator of plant growth is gaining momentum in agriculture. Biostimulants were first restricted to vegetables, fruit crops, and other high-value crops such as ornamental and plantation crops. They now serve a crucial role in the intake of nutrients by traditional food crops such as corn, wheat, and nasturtium by acting as an additional fertilizer in conjunction with fertilizers. Thus, many innovative sources are being developed by key players such as UPL and Valagro S.p.A. Moreover, the developments in genetic engineering are leading to the production of highly effective biostimulants. Market players are increasingly focusing on developing technologies. For instance, in March 2020, Valagro announced the launch of Talete, a new biostimulant, originating from the exclusive GeaPower technology platform, to increase crop water productivity.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific biostimulants market at a substantial CAGR during the forecast period.
Asia Pacific Biostimulants Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Biostimulants Market Segmentation
The Asia Pacific biostimulants market is segmented on the basis of product, application, crop type, and country. Based on product, the market is segmented into humic substances, amino acids, microbial stimulants, seaweed extracts, and others. In 2022, the humic substances segment held a larger share of the market. On the other hand the same segment is expected to register a higher CAGR during the forecast period. Based on application, the Asia Pacific biostimulants market is segmented into foliar spray, seed treatment, and soil application. The foliar spray segment held the largest market share in 2022 and it is also expected to register the highest CAGR in the market during the forecast period. Based on application, the Asia Pacific biostimulants market is segmented into cereals and grains, oilseeds and pulses, fruits and vegetables, turf and landscape, and others. The cereals and grains segment held the largest market share in 2022 and turf and landscape is expected to register the highest CAGR in the market during the forecast period. Based on country, the Asia Pacific biostimulants market is segmented into Australia, China, India, Japan, South Korea, and the Rest of APAC. In 2022, China held the largest market share. It is also expected to register the highest CAGR during the forecast period.
BASF SE, UPL Ltd, Valagro S.P.A., Gowan Company, FMC Corporation, Haifa Negev Technologies Ltd., ADAMA, and Rallis India Limited are among the leading companies in the Asia Pacific biostimulants market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 734.41 Million |
| Market Size by 2028 | US$ 1,419.36 Million |
| CAGR (2022 - 2028) | 11.6% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Biostimulants Market is valued at US$ 734.41 Million in 2022, it is projected to reach US$ 1,419.36 Million by 2028.
As per our report Asia Pacific Biostimulants Market, the market size is valued at US$ 734.41 Million in 2022, projecting it to reach US$ 1,419.36 Million by 2028. This translates to a CAGR of approximately 11.6% during the forecast period.
The Asia Pacific Biostimulants Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Biostimulants Market report:
The Asia Pacific Biostimulants Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Biostimulants Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Biostimulants Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)